by A MartinezMar, 17 2021
Nurse manager Lucy Golding draws up doses of the Moderna COVID-19 vaccine March 14 in Stamford, Conn. Moderna has begun enrolling infants and young children into a vaccine trial. Image: John Moore/Getty Images
The U.S. has administered more than 110 million doses of COVID-19 vaccines, but the vast majority of those jabs are going to adults. Moderna announced Tuesday that it has begun enrolling children from 6 months to less than 12 years old into a trial of its COVID-19 vaccine.
Having the young vaccinated would bring the country "another step closer to actually achieving herd immunity and protecting everybody," says Dr. Steve Plimpton, an OB-GYN in Arizona who is the principal investigator for the Moderna children's trial in Phoenix.